| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.00045 | 1 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.00048 | 1 |